Incident Report
Subform I: General Information
1. Report Type.
New incident report
Incident Report Number: 2025-5849
2. Registrant Information.
Registrant Reference Number: CTVAS036-2024
Registrant Name (Full Legal Name no abbreviations): Corteva Agriscience Canada Company
Address: 240, 115 Quarry Park Road S.E.
City: Calgary
Prov / State: Alberta
Country: Canada
Postal Code: T2C 5G9
3. Select the appropriate subform(s) for the incident.
Scientific Study
4. Date registrant was first informed of the incident.
5. Location of incident.
6. Date incident was first observed.
Product Description
7. a) Provide the active ingredient and, if available, the registration number and product name (include all tank mixes). If the product is not registered provide a submission number.
Active(s)
PMRA Registration No. 34559
PMRA Submission No.
EPA Registration No.
Product Name: Florasulam
PMRA Registration No.
PMRA Submission No.
EPA Registration No.
Product Name:
7. b) Type of formulation.
Application Information
8. Product was applied?
Unknown
9. Application Rate.
10. Site pesticide was applied to (select all that apply).
11. Provide any additional information regarding application (how it was applied, amount applied, the size of the area treated etc).
To be determined by Registrant
12. In your opinion, was the product used according to the label instructions?
Unknown
Subform VII: Scientific Study
1. Study Reference
Title Florasulam: Toxicity to the Aquatic Plant Lemna gibba in a Growth Inhibition Test under Static Conditions
Date 17-DEC-24
2. a) Is an extension needed to translate the document?
No
3. Type of incident identified in the study
Increased health or environmental risk
4. Describe the incident identified in the study (e.g. study demonstrates an increased risk to non-Hodgkin's Lymphoma after exposure to pesticide X)
This study may fall under regulation related to "At levels 50 percent or more lower than previous acute toxicity studies with similar species, including determinations of the median lethal dose (LD50), median lethal concentration (LC50), or median effective concentration (EC50)"
5. a) Was the study discontinued before completion?
No
5. b) Provide the reason for discontinuation
6. If the study is ongoing, what is the expected completion date?
For Registrant use only
7. Provide supplemental information here